Description:

AMC-045 Quality of Life Instruments (QLQ) Phase II Trial Of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7288A090-8102-4969-E040-BB89AD433657

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7288A090-8102-4969-E040-BB89AD433657

Keywords:
Versions (2) ▾
  1. 5/9/12
  2. 8/11/14
Uploaded on:

August 11, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Anal Cancer NCT00324415 Quality of Life - AMC-045 Quality of Life Instruments (QLQ)_2937315v1_0

No Instruction available.

  1. StudyEvent: AMC-045 Quality of Life Instruments (QLQ)
    1. No Instruction available.
Unnamed1
EORTC QLQ-C30 (version 3)
Eortc1
Eortc2
Eortc3
Eortc4
Eortc5
Additional Concerns
During The Past Four Weeks:
Stoma
Only For Patients Without A Stoma (colostomy Bag):
Unnamed 4
Supplemental Quality Of Life Questions